Literature DB >> 25901130

Genetic polymorphisms of NFκB1 -94 del/ins ATTG, NFκB1A 2758 A>G and SUMO rs237025 G>A in psoriasis.

Abdullateef A Alzolibani1, Ahmed Settin2, Ahmed Ali Ahmed2, Hisham Ismail3, Noor Elhefni3, Ahmad A Al Robaee1.   

Abstract

BACKGROUND: Nuclear factor-κB (NF-κB) and small ubiquitin-like modifier (SUMO4) are key transcription factors involved in the regulation of immune responses and apoptosis. The aim of this study is to test for the association of NF-κB and SUMO gene polymorphisms with the susceptibility and severity of psoriasis among Saudi cases. SUBJECTS AND METHODS: This is a case controlled study including 85 Saudi psoriasis patients in addition to 92 matched healthy unrelated controls from the same locality. For all participants, DNA was analyzed by PCR for characterization of NF-κB1 -94 del/ins ATTG, NF-κB IA 2758 A>G and SUMO rs237025 G>A gene polymorphisms.
RESULTS: Compared to controls, psoriasis patients showed a non-significant difference for all frequencies of genotypes and alleles of NF-κB1 ins/del, NF-κB1A A>G and SUMO4 G>A polymorphisms (p>0.05). However, cases with the plaque type had significantly higher frequency of the SUMO4 A allele carriage (GA+AA genoytpes) than the guttate type (78.6% vs. 21.4%, p=0.02). The PASI score was also significantly higher among cases with the NF-κB1A AA genotype than other cases (p=0.00).
CONCLUSION: Genetic polymorphisms of NF-κB1-94 ins/del ATTG, NF-κB IA 2758 A>G and SUMO4 rs237025 G>A were not associated with the susceptibility to psoriasis vulgaris in Saudi patients. However, it might be associated with the expressivity of the disease in terms of its clinical type and severity.

Entities:  

Keywords:  Gene polymorphism; NF-κB; Psoriasis; SUMO4

Year:  2015        PMID: 25901130      PMCID: PMC4394936          DOI: 10.12816/0024680

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  60 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Type 1 diabetes: recent developments.

Authors:  Devasenan Devendra; Edwin Liu; George S Eisenbarth
Journal:  BMJ       Date:  2004-03-27

3.  The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis.

Authors:  L J Gibbons; W Thomson; E Zeggini; J Worthington; A Barton; S Eyre; R Donn; A Hinks
Journal:  Rheumatology (Oxford)       Date:  2005-09-13       Impact factor: 7.580

4.  NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.

Authors:  Matilde Todaro; Monica Zerilli; Giovanni Triolo; Flora Iovino; Mariella Patti; Antonina Accardo-Palumbo; Francesca di Gaudio; Maria Caterina Turco; Antonello Petrella; Ruggero de Maria; Giorgio Stassi
Journal:  Arthritis Rheum       Date:  2005-07

Review 5.  Regulation of NF-kappaB function.

Authors:  Kirsteen J Campbell; Neil D Perkins
Journal:  Biochem Soc Symp       Date:  2006

6.  Association of small ubiquitin-like modifier 4 gene polymorphisms with rheumatoid arthritis in a Tunisian population.

Authors:  E Fakhfakh Karray; I Bendhifallah; L Zakraoui; K Hamzaoui
Journal:  Clin Exp Rheumatol       Date:  2011-09-01       Impact factor: 4.473

7.  Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.

Authors:  Claus Johansen; Esben Flindt; Knud Kragballe; Jeanette Henningsen; Majken Westergaard; Karsten Kristiansen; Lars Iversen
Journal:  J Invest Dermatol       Date:  2005-06       Impact factor: 8.551

8.  Polymorphisms in the 3' untranslated region of the I kappa B/MAD-3 (NFKBI) gene located on chromosome 14.

Authors:  D Glavac; M Ravnik-Glavac; S J O'Brien; M Dean
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

Review 9.  Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis.

Authors:  Frank C Victor; Alice B Gottlieb; Alan Menter
Journal:  Clin Dermatol       Date:  2003 Sep-Oct       Impact factor: 3.541

10.  Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.

Authors:  Shengping Hou; Peizeng Yang; Liping Du; Hongyan Zhou; Xiaomin Lin; Xiaoli Liu; Aize Kijlstra
Journal:  Mol Vis       Date:  2008-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.